Skip to Content

Workers’ Compensation Board

Search menu

Save the Date – COVID-19 and Workers’ Compensation Webinar

Subject Number 046-868 Temporary Suspension of Jonathan Wahl’s Authorization to Treat Injured Workers Effective July 25, 2016

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 232419-2W

August 2, 2016

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Jonathan Wahl’s authorization to treat injured workers within the New York State workers’ compensation system effective July 25, 2016. Dr. Wahl's last known business address is P.O. Box 231, Huntington, New York 11743.

The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Commissioner’s Order of Summary Action # 16-237, wherein Dr. Wahl was directed that, effective immediately, he shall not practice medicine in the State of New York, pending the final conclusion of a hearing held pursuant to the provisions of N.Y. Pub. Health Law §230, and N.Y. State Admin. Proc. Act §§301-307 and 401, for a felony conviction of Conspiracy to Commit Health Care Fraud in violation of 18 U.S.C. §1349, for which he was sentenced to three years of probation, required to pay $200,000 in restitution, a $100 assessment and $563,000 in forfeiture.

Therefore, the Chair believes that Dr. Wahl may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Wahl is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Wahl for services rendered prior to July 25, 2016, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Wahl for services rendered prior to July 25, 2016, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Kenneth J. Munnelly
Chair